Neurogene NGNE
NASDAQ NGNE
$26.83 -0.99 (-3.56%)
As of: Oct 1, 2026 · 3:48 PM EDT

Neurogene (NGNE) Tax Provisions (2013 - 2014)

Updated

Neurogene (NGNE) reported Tax Provisions of -$222.00 for FY2014, compared with -$5,000 in FY2013.

Analysis

Neurogene (NGNE) Tax Provisions (2013 - 2014) Analysis & Trends

  • According to Business Quant data, Tax Provisions came in at -$5,000 in FY2013 and $42,294 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Neurogene 627.40 Mn 627.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 -222.00
Dec 31, 2013 44.00
Sep 30, 2013 -5,044.00
API Access

Neurogene Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=NGNE&period=max&api_key=YOUR_API_KEY